Additionally, how traditional markers such as human epidermal growth factor receptor-2 (HER-2) in GAC and Kirsten rat sarcoma viral oncogene (KRAS) in CRC impact ICI response need to be elucidated. This evidence concerns the gene ERBB2 and colorectal carcinoma.